McIntyre David
Inhibikase Therapeutics, Inc. · Chief Financial Officer
McIntyre David is listed in filings as Chief Financial Officer at Inhibikase Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 7, 2026, including 2 public disclosures. Recent filings connect the profile to Inhibikase Therapeutics, Inc. (IKT). The current snapshot covers public activity from Apr 16, 2025 to Jan 7, 2026. Reported amounts are shown as $3.6M to $2.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||